Genome-wide identification of Chlamydia trachomatis antigens associated with trachomatous trichiasis

Investigative Ophthalmology and Visual Science

Volumn 53, Issue 6, 2012, Pages 2551-2559

  Lu, Chunxue ^a,b   Holland, Martin J ^c,d   Gong, Siqi ^a   Peng, Bo ^a,b   Bailey, Robin L ^c   Mabey, David W ^c   Wu, Yimou ^b   Zhong, Guangming ^a,b  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b UNIVERSITY OF SOUTH CHINA   (China)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d MRC Laboratories   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; BACTERIUM ANTIBODY; CHLAMYDIA TRACHOMATIS ANTIGEN; CHLAMYDIA TRACHOMATIS ANTIGEN CT019; CHLAMYDIA TRACHOMATIS ANTIGEN CT117; CHLAMYDIA TRACHOMATIS ANTIGEN CT301; CHLAMYDIA TRACHOMATIS ANTIGEN CT414; CHLAMYDIA TRACHOMATIS ANTIGEN CT442; CHLAMYDIA TRACHOMATIS ANTIGEN CT553; CHLAMYDIA TRACHOMATIS ANTIGEN CT556; CHLAMYDIA TRACHOMATIS ANTIGEN CT571; CHLAMYDIA TRACHOMATIS ANTIGEN CT667; CHLAMYDIA TRACHOMATIS ANTIGEN CT695; CHLAMYDIA TRACHOMATIS ANTIGEN CT706; CHLAMYDIA TRACHOMATIS ANTIGEN CT709; PROTEOME; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CHLAMYDIA TRACHOMATIS; CHLAMYDOPHILA PNEUMONIAE; CHLAMYDOPHILA PSITTACI; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SEROTYPE; TRICHIASIS;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BIOLOGICAL MARKERS; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; MIDDLE AGED; TRICHIASIS;

EID: 84861140845     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.11-9212     Document Type: Article

References (62)

1. Hu VH, Harding-Esch EM, Burton MJ, Bailey RL, Kadimpeul J, Mabey DC. Epidemiology and control of trachoma: systematic review. Trop Med Int Health. 2010;15:673-691.
2. Starnbach MN, Roan NR. Conquering sexually transmitted diseases. Nat Rev Immunol. 2008;8:313-317.
3. Holland MJ, Jeffries D, Pattison M, et al. Pathway-focused arrays reveal increased matrix metalloproteinase-7 (matrilysin) transcription in trachomatous trichiasis. Invest Ophthalmol Vis Sci. 2010;51:3893-3902.
4. Abu el-Asrar AM, Geboes K, Missotten L. Immunology of trachomatous conjunctivitis. Bull Soc Belge Ophtalmol. 2001; 280:73-96.
5. Holland MJ, Bailey RL, Hayes LJ, Whittle HC, Mabey DC. Conjunctival scarring in trachoma is associated with depressed cell-mediated immune responses to chlamydial antigens. J Infect Dis. 1993;168:1528-1531.
6. Watkins NG, Hadlow WJ, Moos AB, Caldwell HD. Ocular delayed hypersensitivity: a pathogenetic mechanism of chlamydial- conjunctivitis in guinea pigs. Proc Natl Acad Sci U S A. 1986;83:7480-7484.
7. Hu VH, Weiss HA, Ramadhani AM, et al. Innate immune responses and modified extra-cellular matrix regulation characterize bacterial infection and cellular/connective tissue changes in scarring trachoma. Infect Immun. 2012;80:121-130.
8. Hessel T, Dhital SP, Plank R, Dean D. Immune response to chlamydial 60-kilodalton heat shock protein in tears from Nepali trachoma patients. Infect Immun. 2001;69:4996-5000.
9. Skwor T, Kandel RP, Basravi S, Khan A, Sharma B, Dean D. Characterization of humoral immune responses to chlamydial HSP60, CPAF, and CT795 in inflammatory and severe trachoma. Invest Ophthalmol Vis Sci. 2010;51:5128-5136.
10. Peeling RW, Bailey RL, Conway DJ, et al. Antibody response to the 60-kDa chlamydial heat-shock protein is associated with scarring trachoma. J Infect Dis. 1998;177:256-259.
11. Wang J, Chen L, Chen F, et al. A chlamydial type III-secreted effector protein (Tarp) is predominantly recognized by antibodies from humans infected with Chlamydia trachomatis and induces protective immunity against upper genital tract pathologies in mice. Vaccine. 2009;27:2967-2980.
12. Morrison RP. Chlamydial hsp60 and the immunopathogenesis of chlamydial disease. Semin Immunol. 1991;3:25-33.
13. Toye B, Laferriere C, Claman P, Jessamine P, Peeling R. Association between antibody to the chlamydial heat-shock protein and tubal infertility. J Infect Dis. 1993;168:1236-1240.
14. Rodgers AK, Wang J, Zhang Y, et al. Association of tubal factor infertility with elevated antibodies to Chlamydia trachomatis caseinolytic protease P. Am J Obstet Gynecol. 2010;203: 494.e7-494.e14.
15. Bulut Y, Faure E, Thomas L, et al. Chlamydial heat shock protein 60 activates macrophages and endothelial cells through Toll-like receptor 4 and MD2 in a MyD88-dependent pathway. J Immunol. 2002;168:1435-1440.
16. Ausiello CM, Palazzo R, Spensieri F, et al. 60-kDa heat shock protein of Chlamydia pneumoniae is a target of T-cell immune response. J Biol Regul Homeost Agents. 2005;19: 136-140.
17. Kinnunen A, Paavonen J, Surcel HM. Heat shock protein 60 specific T-cell response in chlamydial infections. Scand J Immunol. 2001;54:76-81.
18. Ausiello CM, Fedele G, Palazzo R, Spensieri F, Ciervo A, Cassone A. 60-kDa heat shock protein of Chlamydia pneumoniae promotes a T helper type 1 immune response through IL-12/IL-23 production in monocyte-derived dendritic cells. Microbes Infect. 2006;8:714-720.
19. Cappello F, Conway de Macario E, Di Felice V, Zummo G, Macario AJ. Chlamydia trachomatis infection and anti-Hsp60 immunity: the two sides of the coin. PLoS Pathog. 2009;5: e1000552.
20. Domeika M, Domeika K, Paavonen J, Mardh PA, Witkin SS. Humoral immune response to conserved epitopes of Chlamydia trachomatis and human 60-kDa heat-shock protein in women with pelvic inflammatory disease. J Infect Dis. 1998; 177:714-719.
21. Rodgers AK, Budrys NM, Gong S, et al. Genome-wide identification of Chlamydia trachomatis antigens associated with tubal factor infertility. Fertil Steril. 2011;96:715-721.
22. Burton MJ, Rajak SN, Bauer J, et al. Conjunctival transcriptome in scarring trachoma. Infect Immun. 2011;79:499-511.
23. Gall A, Horowitz A, Joof H, et al. Systemic effector and regulatory immune responses to chlamydial antigens in trachomatous trichiasis. Front Microbiol. 2011;2:10.
24. Hudson L, Hay FC. Practical Immunology. 3rd ed. Oxford: Blackwell Scientific Publications; 1989.
25. Zhong G, Fan P, Ji H, Dong F, Huang Y. Identification of a chlamydial protease-like activity factor responsible for the degradation of host transcription factors. J Exp Med. 2001; 193:935-942.
26. Wang J, Zhang Y, Lu C, Lei L, Yu P, Zhong GA. Genome-wide profiling of the humoral immune response to Chlamydia trachomatis infection reveals vaccine candidate antigens expressed in humans. J Immunol. 2010;185:1670-1680.
27. Li Z, Chen D, Zhong Y, Wang S, Zhong G. The chlamydial plasmid-encoded protein pgp3 is secreted into the cytosol of Chlamydia-infected cells. Infect Immun. 2008;76:3415-3428.
28. Luo J, Liu G, Zhong Y, et al. Characterization of hypothetical proteins Cpn0146, 0147, 0284 & 0285 that are predicted to be in the Chlamydia pneumoniae inclusion membrane. BMC Microbiol. 2007;7:38.
29. Greene W, Zhong G. Inhibition of host cell cytokinesis by Chlamydia trachomatis infection. J Infect. 2003;47:45-51.
30. Sharma J, Zhong Y, Dong F, Piper JM, Wang G, Zhong G. Profiling of human antibody responses to Chlamydia trachomatis urogenital tract infection using microplates arrayed with 156 chlamydial fusion proteins. Infect Immun. 2006;74:1490-1499.
31. Li Z, Chen C, Chen D, Wu Y, Zhong Y, Zhong G. Characterization of fifty putative inclusion membrane proteins encoded in the Chlamydia trachomatis genome. Infect Immun. 2008;76:2746-2757.
32. Dean D, Kandel RP, Adhikari HK, Hessel T. Multiple Chlamydiaceae species in trachoma: implications for disease pathogenesis and control. PLoS Med. 2008;5:e14.
33. Stekel DJ, Sarti D, Trevino V, et al. Analysis of host response to bacterial infection using error model based gene expression microarray experiments. Nucleic Acids Res. 2005;33:e53.
34. Stekel DJ. Microarray Bioinformatics. 1st ed. New York, NY: Cambridge University Press; 2003.
35. Feise RJ. Do multiple outcome measures require p-value adjustment? BMC Med Res Methodol. 2002;2:8.
36. Hu VH, Massae P, Weiss HA, et al. Bacterial infection in scarring trachoma. Invest Ophthalmol Vis Sci. 2011;52:2181-2186.
37. Burton MJ, Bailey RL, Jeffries D, et al. Conjunctival expression of matrix metalloproteinase and proinflammatory cytokine genes after trichiasis surgery. Invest Ophthalmol Vis Sci. 2010; 51:3583-3590.
38. Zhong G, Liu L, Fan T, Fan P, Ji H. Degradation of transcription factor RFX5 during the inhibition of both constitutive and interferon gamma-inducible major histocompatibility complex class I expression in Chlamydia-infected cells. J Exp Med. 2000;191:1525-1534.
39. Zhong G, Fan T, Liu L. Chlamydia inhibits interferon gammainducible major histocompatibility complex class II expression by degradation of upstream stimulatory factor 1. J Exp Med. 1999;189:1931-1938.
40. Pirbhai M, Dong F, Zhong Y, Pan KZ, Zhong G. The secreted protease factor CPAF is responsible for degrading proapoptotic BH3-only proteins in Chlamydia trachomatisinfected cells. J Biol Chem. 2006;281:31495-31501.
41. Clifton DR, Fields KA, Grieshaber SS, et al. A chlamydial type III translocated protein is tyrosine-phosphorylated at the site of entry and associated with recruitment of actin. Proc Natl Acad Sci U S A. 2004;101:10166-10171.
42. Engel J. Tarp and arp: how Chlamydia induces its own entry. Proc Natl Acad Sci U S A. 2004;101:9947-9948.
43. Lutter EI, Bonner C, Holland MJ, et al. Phylogenetic analysis of Chlamydia trachomatis Tarp and correlation with clinical phenotype. Infect Immun. 2010;78:3678-3688.
44. Hower S, Wolf K, Fields KA. Evidence that CT694 is a novel Chlamydia trachomatis T3S substrate capable of functioning during invasion or early cycle development. Mol Microbiol. 2009;72:1423-1437.
45. Fields KA, Hackstadt T. Evidence for the secretion of Chlamydia trachomatis CopN by a type III secretion mechanism. Mol Microbiol. 2000;38:1048-1060.
46. Kalman S, Mitchell W, Marathe R, et al. Comparative genomes of Chlamydia pneumoniae and C. trachomatis. Nat Genet. 1999;21:385-389.
47. Caldwell HD, Wood H, Crane D, et al. Polymorphisms in Chlamydia trachomatis tryptophan synthase genes differentiate between genital and ocular isolates. J Clin Invest. 2003; 111:1757-1769.
48. Gaydos CA, Palmer L, Quinn TC, Falkow S, Eiden JJ. Phylogenetic relationship of Chlamydia pneumoniae to Chlamydia psittaci and Chlamydia trachomatis as determined by analysis of 16S ribosomal DNA sequences. Int J Syst Bacteriol. 1993;43:610-612.
49. Grinblat-Huse V, Drabek EF, Creasy HH, et al. Genome sequences of the zoonotic pathogens Chlamydia psittaci 6BC and Cal10. J Bacteriol. 2011;193:4039-4040.
50. Andreasen AA, Burton MJ, Holland MJ, et al. Chlamydia trachomatis ompA variants in trachoma: what do they tell us? PLoS Negl Trop Dis. 2008;2:e306.
51. Hayes LJ, Pecharatana S, Bailey RL, et al. Extent and kinetics of genetic change in the omp1 gene of Chlamydia trachomatis in two villages with endemic trachoma. J Infect Dis. 1995;172: 268-272.
52. Carlson JH, Porcella SF, McClarty G, Caldwell HD. Comparative genomic analysis of Chlamydia trachomatis oculotropic and genitotropic strains. Infect Immun. 2005;73:6407-6418.
53. Carlson JH, Hughes S, Hogan D, et al. Polymorphisms in the Chlamydia trachomatis cytotoxin locus associated with ocular and genital isolates. Infect Immun. 2004;72:7063-7072.
54. Bannantine JP, Griffiths RS, Viratyosin W, Brown WJ, Rockey DD. A secondary structure motif predictive of protein localization to the chlamydial inclusion membrane. Cell Microbiol. 2000;2:35-47.
55. Bannantine JP, Rockey DD, Hackstadt T. Tandem genes of Chlamydia psittaci that encode proteins localized to the inclusion membrane. Mol Microbiol. 1998;28:1017-1026.
56. Roy PH, Tetu SG, Larouche A, et al. Complete genome sequence of the multiresistant taxonomic outlier Pseudomonas aeruginosa PA7. PLoS One. 2010;5:e8842.
57. Zhang YX, Watkins NG, Stewart S, Caldwell HD. The lowmolecular- mass, cysteine-rich outer membrane protein of Chlamydia trachomatis possesses both biovar- and speciesspecific epitopes. Infect Immun. 1987;55:2570-2573.
58. Starnbach MN, Loomis WP, Ovendale P, et al. An inclusion membrane protein from Chlamydia trachomatis enters the MHC class I pathway and stimulates a CD8+T cell response. J Immunol. 2003;171:4742-4749.
59. Clements C, Dhir SP, Grayston JT, Wang SP. Long term followup study of a trachoma vaccine trial in villages of Northern India. Am J Ophthalmol. 1979;87:350-353.
60. Grayston JT, Woolridge RL, Wang S. Trachoma vaccine studies on Taiwan. Ann N Y Acad Sci. 1962;98:352-367.
61. Sowa S, Sowa J, Collier LH, Blyth WA. Trachoma vaccine field trials in The Gambia. J Hyg (Lond). 1969;67:699-717.
62. Woolridge RL, Grayston JT, Chang IH, Yang CY, Cheng KH. Long-term follow-up of the initial (1959-1960) trachoma vaccine field trial on Taiwan. Am J Ophthalmol. 1967;63: Suppl:1650-1655.